Introduction

Central and Eastern European Proteomic Conference (CEEPC) provides a platform for researchers to discuss multi-disciplinary integrated approaches to address a range of challenges from present day viral pandemic to on-going progress in Precision Medicine. CEEPC brings together various multi-omics entwined with novel enabling technologies, thus facilitating conceptual advances from cell to society for the benefit of mankind.

Areas covered

Proteomic methodologies, databases and software has revolutionized our ability to assess protein interactions and cellular changes, allowing the establishment of biological connections and identification of important cellular regulatory proteins and pathways previously unknown or not fully understood. Additionally, Mass spectrometry (MS) remains a major driving force in the field of ‘multi-omics’ and a powerful technology for the structural characterization of biomolecules and for analysis of proteins and small molecules such as lipids, sugars and metabolites. Combination of measurements from proteomics, genomics, epigenomics, transcriptomics and metabolomics, present a powerful decision-making format allowing deeper interpretation of a disease scenario in Precision medicine.

Expert commentary

Precision Medicine offers novel and promising ways to identify and treat a wide range of diseases. The future success of these therapies will be underpinned by novel proteo-genomic approaches linked to sophisticated databases to evaluate and predict drug-patient interactions.

中文翻译：

---

蛋白质组学的力量和精准医学的进步 - 第 13 届中东欧蛋白质组学会议 (CEEPC)，波兰乌斯特朗。

简介

中欧和东欧蛋白质组学会议 (CEEPC) 为研究人员提供了一个讨论多学科综合方法的平台，以应对从当今病毒大流行到精准医学持续进步的一系列挑战。CEEPC 将各种多组学与新型使能技术相结合，从而促进从细胞到社会的概念进步，造福人类。

覆盖区域

蛋白质组学方法、数据库和软件彻底改变了我们评估蛋白质相互作用和细胞变化的能力，允许建立生物学联系并鉴定以前未知或尚未完全了解的重要细胞调节蛋白和途径。此外，质谱 (MS) 仍然是“多组学”领域的主要推动力，是生物分子结构表征以及蛋白质和小分子（如脂质、糖和代谢物）分析的强大技术。蛋白质组学、基因组学、表观基因组学、转录组学和代谢组学的测量组合，提供了一种强大的决策格式，可以更深入地解释精准医学中的疾病场景。

专家评论

精准医学提供了新颖且有前景的方法来识别和治疗多种疾病。这些疗法未来的成功将得到与复杂数据库相关联的新型蛋白质基因组方法的支持，以评估和预测药物与患者的相互作用。